Merck (MRK) Cash from Investing Activities Growth (5y) (2014 - 2026)

Merck (MRK) Cash from Investing Activities Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -71.61%
Dec 31, 2025 -18.98%
Sep 30, 2025 32.94%
Jun 30, 2025 0.31%
Mar 31, 2025 1.80%
Dec 31, 2024 -16.85%
Sep 30, 2024 -85.78%
Jun 30, 2024 15.11%
Mar 31, 2024 -41.83%
Dec 31, 2023 -52.44%
Sep 30, 2023 -17.09%
Jun 30, 2023 -80.20%
Mar 31, 2023 -64.31%
Dec 31, 2022 -97.62%
Sep 30, 2022 -27.98%
Jun 30, 2022 0.90%
Mar 31, 2022 -18.81%
Dec 31, 2021 -36.28%
Sep 30, 2021 -3.58%
Jun 30, 2021 -11.87%